Finance

Lists
PTIX:OTCMKTS
Protagenic Therapeutics Inc
$0.80
+33.52%
(+0.20) 1D
Aug 21, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PTIX...
Open
$0.65
High
$0.91
Low
$0.63
Mkt. cap
1.45M
Avg. vol.
7.80K
Volume
140.56K
52-wk high
$5.15
52-wk low
$0.13
Beta
0.99
Shares outstanding
1.81M
No. of employees
3
Open
$0.65
High
$0.91
Low
$0.63
Mkt. cap
1.45M
Avg. vol.
7.80K
Volume
140.56K
52-wk high
$5.15
52-wk low
$0.13
Beta
0.99
Shares outstanding
1.81M
No. of employees
3
News stories
From web sources and news partners
About Protagenic Therapeutics Inc
CEO-
Employees3
Founded1994
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
394.11K
273.23K
153.79K
80.77K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
814.26K
840.64K
771.32K
757.01K
Operating expense
1.21M
1.11M
925.10K
120.33K
Total operating expenses
1.21M
1.11M
925.10K
120.33K
Operating income
-1.21M
-1.11M
-925.10K
-120.33K
Other non operating income
-3.61M
237.69K
3.14M
-791.70K
EBT including unusual items
-5.06M
-869.50K
2.21M
5.08M
EBT excluding unusual items
-5.06M
-869.50K
2.21M
-2.23M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.06M
-869.50K
2.21M
5.08M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-238.73K
-
-
-1.31M
Net interest expenses
-238.73K
-
-
-1.31M
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.20M
-1.10M
-912.53K
-108.83K
Gain or loss from assets sale
-
-
-
-7.31M
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps